Exagen Insider Sold Shares Worth $269,791, According to a Recent SEC Filing

MT newswire2026/10/19 20:56

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

04:56 PM EDT, 10/19/2026 (MT Newswires) -- John Aballi, Director, President and CEO, on October 16, 2026, sold 34,294 shares in Exagen (XGN) for $269,791. Following the Form 4 filing with the SEC, Aballi has control over a total of 845,941 common shares of the company, with 805,540 shares held directly and 40,401 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1274737/000184311326000009/xslF345X05/wk-form4_1792443148.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Exagen Insider Sold Shares Worth $269,791, According to a Recent SEC Filing

You may also like

Crypto prices